• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388).

作者信息

Luce J K, Thurman W G, Isaacs B L, Talley R W

出版信息

Cancer Chemother Rep. 1970 Apr;54(2):119-24.

PMID:4334086
Abstract
摘要

相似文献

1
Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388).使用抗肿瘤药物5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC-45388）的临床试验。
Cancer Chemother Rep. 1970 Apr;54(2):119-24.
2
Hexamethylmelamine (NSC-13875) alone and in combination with 5-(3, 3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388) in the treatment of advanced cancer.
Cancer. 1972 Sep;30(3):654-9. doi: 10.1002/1097-0142(197209)30:3<654::aid-cncr2820300312>3.0.co;2-x.
3
5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma.5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC-45388）用于胃肠道癌患者。
Cancer Chemother Rep. 1970 Dec;54(6):471-3.
4
5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma.
Eur J Cancer (1965). 1972 Feb;8(1):85-92. doi: 10.1016/0014-2964(72)90087-4.
5
Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma.5-（3,3-双（2-氯乙基）-1-三氮烯基）咪唑-4-甲酰胺（NSC-82196）治疗转移性恶性黑色素瘤的临床经验
Cancer Chemother Rep. 1972 Oct;56(5):671-7.
6
[Polychemotherapy with 5-(3,3 dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) and vincristine (NSC-67574) in the metastatic phase of melanoma].[采用5-(3,3-二甲基-1-三氮烯基)咪唑-4-甲酰胺（达卡巴嗪；NSC-45388）、1,3-双(2-氯乙基)-1-亚硝基脲（卡莫司汀，NSC-409962）和长春新碱（NSC-67574）对黑色素瘤转移期进行多药化疗]
Tumori. 1973 May-Jun;59(3):239-48. doi: 10.1177/030089167305900305.
7
5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of advanced acute lymphocytic leukemia in children.
Cancer Chemother Rep. 1972 Aug;56(4):523-6.
8
5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma.
Cancer Chemother Rep. 1972 Oct;56(5):667-70.
9
Study of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with disseminated melanoma.5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC-45388）治疗播散性黑色素瘤患者的研究。
Cancer Chemother Rep. 1973 Feb;57(1):83-4.
10
5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of malignant tumors other than melanoma.
Cancer Chemother Rep. 1971 Jun;55(3):281-3.

引用本文的文献

1
Prognostic nomogram for external ear melanoma patients in the elderly: a SEER-based study.老年外耳道黑色素瘤患者的预后列线图：一项基于 SEER 的研究。
J Cancer Res Clin Oncol. 2023 Oct;149(13):12241-12248. doi: 10.1007/s00432-023-05098-y. Epub 2023 Jul 11.
2
Translating Molecules into Imaging-The Development of New PET Tracers for Patients with Melanoma.将分子转化为成像——黑色素瘤患者新型正电子发射断层显像（PET）示踪剂的研发
Diagnostics (Basel). 2022 Apr 29;12(5):1116. doi: 10.3390/diagnostics12051116.
3
State of melanoma: an historic overview of a field in transition.
黑色素瘤的现状：一个处于转型期领域的历史概述
Hematol Oncol Clin North Am. 2014 Jun;28(3):415-35. doi: 10.1016/j.hoc.2014.02.010.
4
A phase I clinical and pharmacological profile of dacarbazine with autologous bone marrow transplantation in patients with solid tumors.达卡巴嗪联合自体骨髓移植治疗实体瘤患者的I期临床及药理学研究
Invest New Drugs. 1993 May-Aug;11(2-3):169-79. doi: 10.1007/BF00874151.
5
Chemotherapy of malignant melanoma with dimethyl traizeno imidazole carboxamide (DITC) and nitrosourea derivatives (BCNU, CCNU).用二甲基三嗪咪唑甲酰胺（DITC）和亚硝基脲衍生物（卡莫司汀、洛莫司汀）治疗恶性黑色素瘤。
Ann Surg. 1974 Aug;180(2):167-74. doi: 10.1097/00000658-197408000-00007.
6
N-methyl antitumour agents. A distinct class of anticancer drugs?N-甲基抗肿瘤药物。一类独特的抗癌药物？
Cancer Chemother Pharmacol. 1987;19(2):91-102. doi: 10.1007/BF00254559.
7
Clinical pharmacokinetics of high-dose DTIC.大剂量达卡巴嗪的临床药代动力学
Cancer Chemother Pharmacol. 1991;28(6):475-9. doi: 10.1007/BF00685826.
8
Active immunotherapy as an adjunct to chemotherapy in the treatment of disseminated malignant melanoma: a pilot study.主动免疫疗法作为化疗辅助手段治疗播散性恶性黑色素瘤的一项初步研究。
Br J Cancer. 1975 Feb;31(2):143-56. doi: 10.1038/bjc.1975.19.